checkAd
    Startseite > Aktien > Vericel > Nachrichten
    Vericel Aktie
    43,20
     
    EUR
    +1,89 %
    +0,80 EUR
    Letzter Kurs 26.04.24 Tradegate
    42,60
     
    EUR
    71 STK
    Geldkurs 10:00:18
    43,60
     
    EUR
    69 STK
    Briefkurs 10:00:18
    ISIN: US92346J1088 · WKN: A12FU4 · SYM: ATQP · USA

    Neueste Nachrichten

    Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
    24.04.24 · globenewswire · Vericel
    Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
    29.02.24 · globenewswire · Vericel
    Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
    27.02.24 · globenewswire · Vericel
    Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
    15.02.24 · globenewswire · Vericel
    Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
    05.02.24 · globenewswire · Vericel
    Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results
    09.01.24 · globenewswire · Vericel
    Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024
    03.01.24 · globenewswire · Vericel
    Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance
    08.11.23 · globenewswire · Vericel
    Vericel to Present at the Stephens Annual Investment Conference
    07.11.23 · globenewswire · Vericel
    Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023
    25.10.23 · globenewswire · Vericel
    Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
    28.09.23 · globenewswire · Vericel
    Vericel Announces U.S. Commercial Availability of NexoBrid (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults
    20.09.23 · globenewswire · Vericel